Our exploratory survival analysis further indicated that elevated LGALS3 expression correlates with poorer overall survival in PDAC and several other tumor types, including low-grade glioma (LGG), uveal melanoma (UVM), and kidney renal papillary cell carcinoma (KIRP). This evidence concerns the gene LGALS3 and low grade glioma.